OrbiMed launches USD924m Royalty & Credit Opportunities Fund
OrbiMed has held the closing of its second healthcare royalty and credit opportunities Fund, OrbiMed Royalty Opportunities II, with USD924 million in commitments, including USD24 million from the General Partner. Investors in the fund include a broad range of premier endowment, foundation, pension and other institutional investors. Consistent with its






